In a remarkable demonstration of medical expertise, CMRI Kolkata has successfully performed a highly intricate surgery on a patient of 72 years with a history of pancreatic cancer and hernia.

About 61% of patients with stage I or II dMMR colon cancer achieved a pathologic complete response after a single cycle of neoadjuvant pembrolizumab, new data revealed.

Our outstanding team at Mission Hospital continues to raise the bar in providing exceptional care to our patients,” said Greg Lowe, chief executive officer of Mission Hospital and Mission Health.

The FDA granted priority review for belzutifan for treating advanced pheochromocytoma and paraganglioma, with a PDUFA date ...

A data analysis from a randomized clinical trial for stage 3 colon cancer patients by investigators at Dana-Farber Brigham ...

Although ctDNA positivity generally meant worse disease-free survival in stage 3 resected colon cancer, patients with ctDNA ...

The Alliance for Clinical Trials in Oncology today announced the results of a data analysis from a randomized phase III clinical trial involving patients with stage III colon cancer, which found that ...

Exelixis, Inc. (Nasdaq: EXEL) today announced results from a subgroup analysis of the phase 3 CABINET pivotal study of ...

Clinically significant reductions in bleeding underscore abelacimab’s strong potential to address an unmet need for patients ...

Agenus Presents Data at ASCO GI Demonstrating Impact of BOT/BAL in Colorectal Cancer Across Neoadjuvant and Advanced Disease ...

For obstructive sleep apnea, a CPAP machine is prescribed. However, sometimes surgery is recommended for severe cases of obstructive sleep apnea or when other therapies aren’t effective.